The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
11.35
+0.40 (3.65%)
Nov 20, 2024, 4:00 PM EST - Market closed
The Joint Market Cap
The Joint has a market cap or net worth of $170.06 million as of November 21, 2024. Its market cap has increased by 48.53% in one year.
Market Cap
170.06M
Enterprise Value
158.78M
1-Year Change
48.53%
Ranking
Category
Stock Price
$11.35
Market Cap Chart
Since November 11, 2014, The Joint's market cap has increased from $60.30M to $170.06M, an increase of 182.03%. That is a compound annual growth rate of 10.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 164.10M | 15.73% |
| Dec 29, 2023 | 141.80M | -30.18% |
| Dec 30, 2022 | 203.10M | -78.55% |
| Dec 31, 2021 | 946.80M | 156.79% |
| Dec 31, 2020 | 368.70M | 64.75% |
| Dec 31, 2019 | 223.80M | 95.80% |
| Dec 31, 2018 | 114.30M | 70.34% |
| Dec 29, 2017 | 67.10M | 99.11% |
| Dec 30, 2016 | 33.70M | -42.98% |
| Dec 31, 2015 | 59.10M | -4.68% |
| Dec 31, 2014 | 62.00M | 2.82% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 175.87M |
| Biodesix | 173.11M |
| Stereotaxis | 172.00M |
| DiaMedica Therapeutics | 171.92M |
| Heron Therapeutics | 170.35M |
| Adaptimmune Therapeutics | 169.99M |
| Greenwich LifeSciences | 168.91M |
| Verastem | 168.68M |